Clearmind MedicineCMND

13F holders, Q4 2024 (December 31)
9holders +1
3new positions
2sold out
2famous investors
$8.96avg. 13F price*

At the end of Q4 2024, 9 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, up 1 from Q3 2024. 3 opened new positions and 2 sold out. The largest holders were Gotham Asset Management ($5.1M), AdvisorShares Investments LLC ($232K) and Virtu Financial LLC ($54K). 2 famous investors held it, including Joel Greenblatt (0.0% of Gotham Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Clearmind Medicine Inc.
CUSIP
185053402
Latest filing quarter
Q3 2025

History

Number of 13F holders

0246810 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 8Q3 2024Q4 2024: 9Q4 2024Q1 2025: 7Q1 2025Q2 2025: 9Q2 2025Q3 2025: 7Q3 2025

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions3$59K
Exits2$187K

All 13F filers, Q3 2024 → Q4 2024: 67,263 shares bought and 156,878 shares sold, net −89,615 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 9 holders

Gotham Asset Management 0.05% Add +1.1% 342,864 $5.1M
AdvisorShares Investments LLC 0.04% Reduce -1.6% 167,856 $232K
Virtu Financial LLC 0.00% New 39,479 $54K
Citadel Advisors 0.00% Add +115.2% 38,158 $53K
Cornerstone Wealth Group, LLC 0.00% No change 20,000 $28K
Morgan Stanley 0.00% New 2,564 $4K
Tower Research Capital LLC (TRC) 0.00% New 935 $1K
Royal Bank of Canada 0.00% No change 569 $1K
National Bank of Canada 0.00% No change 379 $523

"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.